Clinical Trial Update: Clinical Study on the Safety and Efficacy of Human Amniotic Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical study is evaluating the safety and efficacy of human amniotic mesenchymal stem cells for treating premature ovarian insufficiency, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ovarian Insufficiency

Drugs mentioned

• Human Amniotic Mesenchymal Stem Cells (amniotic mesenchymal stem cells)

Snippet

Sponsor: Yan Hongli | Conditions: Premature Ovarian Insufficiency | Phase 1, Phase 2 | Status: RECRUITING